In addition, the activation of NF-κB associates with the upregulation of cell proliferation enhancers (e.g., cyclin D1 and c-myc), cell adhesion molecules, and several angiogenesis factors enhance cancer cell engraftment (e.g., ICAM-1 and VEGF) [37,38,39,40,41,42,43]. Here, MYC is linked to cancer.